[Federal Register Volume 62, Number 172 (Friday, September 5, 1997)] [Notices] [Page 47070] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 97-23610] ----------------------------------------------------------------------- NUCLEAR REGULATORY COMMISSION Advisory Committee on the Medical Uses of Isotopes: Meeting Notice AGENCY: U.S. Nuclear Regulatory Commission. ACTION: Notice of meeting. ----------------------------------------------------------------------- SUMMARY: The U.S. Nuclear Regulatory Commission will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on September 25-26, 1997. The meeting will take place at the address provided below. All sessions of the meeting will be open to the public, except where specifically noted otherwise. Topics of discussion will include: (1) An evaluation of the ACMUI and the composition of its membership; (2) an update on the revision of 10 CFR part 35 and associated activities; (3) a discussion of the requirements for (a) a Quality Management Program, (b) a radiation safety committee, (c) training and experience, and (d) notification of patients; (4) a discussion of possible options for revising the 1979 Medical Policy Statement; and (5) a discussion of previous ACMUI recommendations. Additionally, the staff will provide an update on several rulemakings and regulatory guides: (1) Rulemaking for part 33, ``Specific Domestic Licenses of Broad Scope for Byproduct Material;'' (2) petition for rulemaking for carbon-14 use; (3) petition from the University of Cincinnati regarding 10 CFR 20.1301, and (4) radiopharmacy guidance. In addition, on September 25, 1997, from 8:00 a.m. to 8:30 a.m., there will be a closed session of the ACMUI to discuss ethics rules and their application. This session will be closed on the grounds that the meeting will relate solely to internal personnel rules and/or practices of the agency and will involve information the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. DATES: The meeting will begin at 8:30 a.m., on September 25, 1997, and 8:00 a.m. on September 26, 1997. ADDRESSES: U.S. Nuclear Regulatory Commission, Two White Flint North, 11545 Rockville Pike, Room T2B3, Rockville, MD 20852-2738. FOR FURTHER INFORMATION CONTACT: Diane Flack, U.S. Nuclear Regulatory Commission, Office of Nuclear Material Safety and Safeguards, MS T8F5, Washington, DC 20555, Telephone (301) 415-5681. Conduct of the Meeting Judith Ann Stitt, M.D., will chair the meeting. Dr. Stitt will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting: 1. Persons who wish to provide a written statement should submit a reproducible copy to Diane Flack (address listed previously), by September 18, 1997. Statements must pertain to the topics on the agenda for the meeting. 2. At the meeting, questions from members of the public will be permitted at the discretion of the Chairman. 3. The transcript and written comments will be available for inspection, and copying, for a fee, at the NRC Public Document Room, 2120 L Street, N.W., Lower Level, Washington, DC 20555, telephone (202) 634-3273, on or about October 3, 1997. Minutes of the meeting will be available on or about November 14, 1997. 4. Seating for the public will be on a first-come, first-served basis. This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the Commission's regulations in Title 10, U.S. Code of Federal Regulations, part 7. Dated: August 29, 1997. Kenneth R. Hart, Acting Secretary of the Commission. [FR Doc. 97-23610 Filed 9-4-97; 8:45 am] BILLING CODE 7590-01-P